Adriamycin Rapid Dissolution (Doxorubicin Hydrochloride) 50mg

Adriamycin Rapid Dissolution contains doxorubicin hydrochloride 50mg for injection. This chemotherapy agent is used to treat various cancers by slowing or stopping cell growth. It is administered under medical supervision. Commonly prescribed for solid tumors and hematologic malignancies.

Strength

50mg

Pack Size

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Adriamycin Rapid Dissolution is used to treat a range of cancers including breast cancer, bladder cancer, lymphoma, and leukemia. It may be prescribed for both adult and pediatric patients depending on the cancer type. The medication works by interfering with DNA replication in rapidly dividing cells. Patients often ask, what is doxorubicin hydrochloride used for in cancer treatment.

Side Effects

This medication may cause temporary hair thinning or loss as a common effect. Some patients report mild nausea or fatigue following administration. The rapid dissolution formulation aims to reduce preparation time for healthcare providers. Individual responses vary based on treatment protocol and health status.

Precautions & Warnings

Adriamycin Rapid Dissolution should only be handled and administered by healthcare professionals. Patients must inform providers about all current medications and health conditions before treatment. Regular blood tests are typically required during therapy to monitor for potential complications. Proper disposal of unused medication is essential.

Avoid Interactions

Certain medications may interact with doxorubicin, including some chemotherapy drugs and blood pressure medications. Patients should avoid grapefruit products during treatment. Alcohol consumption may increase side effects like nausea. Always disclose all prescription, over-the-counter, and herbal supplements to your healthcare provider.

Frequently Asked Questions

This medication is given as an intravenous injection or infusion by a healthcare professional in a clinical setting.

Common effects may include hair loss, nausea, fatigue, and changes in blood cell counts.

Many medications may interact with doxorubicin; always inform your doctor about all medications you're taking.

Doxorubicin is prescribed for specific cancer types; your doctor will determine if it's appropriate for your condition.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.